SCHEDULE: Donahue Boosts Mainz Biomed Stake to 10.7%
Beneficial Ownership Disclosure
Kevin Michael Donahue has reported increasing his beneficial ownership in Mainz Biomed N.V. to 10.7% of common stock.
Summary
- Kevin Michael Donahue reported beneficial ownership of 685,000 shares of Mainz Biomed N.V. common stock.
- This ownership represents 10.7% of the total class of securities.
- Donahue holds sole voting power and sole dispositive power over all 685,000 shares.
- The filing is an Amendment No. 1 to a Schedule 13G, indicating an update to a previous ownership disclosure.
Sentiment
Score: 6
Explanation: The filing indicates a significant beneficial ownership stake by an individual, which can be viewed as a positive signal of confidence. However, it is a purely factual disclosure and does not contain performance or strategic updates, leading to a moderately positive sentiment.
Positives
- The disclosure of a significant individual stake (10.7%) by Kevin Michael Donahue could be interpreted as a vote of confidence in Mainz Biomed N.V.
Negatives
- The filing itself does not present any negative information regarding the company's operations or financial health; it is purely a disclosure of beneficial ownership.
Risks
- NA
Future Outlook
NA
Management Comments
- NA
Industry Context
NA
Comparison to Industry Standards
- NA
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| NA | NA | NA | NA | NA |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| NA | NA | NA | NA |
Legal Proceedings
- NA
Related Party Transactions
- NA
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant individual shareholder's position, which may influence investor sentiment.
Next Steps
- NA
Key Dates
| Date | Description |
|---|---|
| 10/17/2025 | Date of event which requires filing of this statement |
| 01/20/2026 | Signature date of the filing |
Keywords
Mainz Biomed N.V., Common Stock, N5436L101, Kevin Donahue, Beneficial Ownership, Schedule 13G, Insider Ownership, Biomedical
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.